Discussion about the Role of Ghrelin in Myocardial Ischemia/Reperfusion and its Possible Mechanism

ABSTRACT

Background: Ghrelin in the gastric mucosa of rats can improve myocardial cell apoptosis and cardiac remodeling during myocardial ischemia and myocardial infarction, and it has a protective effect on the myocardium, but its mechanism is unclear. Objectives: The rat myocardial ischemia/reperfusion (I/R) model was established to investigate Ghrelin’s role in the disease’s pathogenesis. Materials and Methods: The study subjects were 80 male and female Sprague-Dawley (SD) rats: Sham operation group, I/R model control group, I/R + Ghrelin group, and I/R + Ghrelin + 5-hydroxydecanoic acid salt (5-HD) group. Before surgery, rats in the I/R + Ghrelin group were given Ghrelin 100 µg/kg intravenously, and those in the I/R + Ghrelin + 5-HD group were given 100 µg/kg and 5-HD 5 mg/kg. An I/R model was made, and a cardiac ultrasound index was detected after reperfusion. The venous blood of rats in each group was taken, with the values of the myocardial enzyme creatine kinase (CK), troponin I (cTnI), and so on. Malondialdehyde (MDA) and adenosine triphosphate (ATP) were measured from the myocardial tissues of rats. Mitochondrial protein was extracted from the ischemic myocardium cells of rats in each group, and the content of C×43 protein in the mitochondria was detected. Results: After reperfusion, it was found that left ventricular developed pressure (LVDP), left ventricular ejection fraction (LVEF), and left ventricular fractional shortening (LVFS) in the echocardiogram of the I/R model control group were significantly decreased, and the difference was statistically significant compared with the sham operation group (p < .001). LVDP, LVEF, and LVFS in the I/R + Ghrelin group were significantly higher than those in the I/R model control group, and the difference was statistically significant (p < .001). At the end of reperfusion, myocardial troponin and other data, as well as MDA content in the peripheral blood of the control group, were different from those in the sham operation group (p < .05). The former ATP value was lower than the latter (p < .05). The CK, CK-myocardial band (CK-MB), and cTnI values in the I/R + Ghrelin group were lower than those in the good group (p < .05). Mitochondria were isolated from rat myocardial cells in each group. After reperfusion, C×43 data in the control group were lower than those in other groups. After pretreatment with Ghrelin, related expressions were unchanged. After 5-HD was added, the expression of C×43 decreased slightly, but it was not obvious. The content of MDA in the I/R + Ghrelin + GHRP-6 group was significantly increased, which was not significantly different from that in the I/R + Ghrelin + 5-HD group. Still, the expression was reversed considerably compared with that in the I/R + Ghrelin group, and the difference was statistically significant (p < .001). After the intervention of GHRP-6, ATP content in the myocardial tissue of rats in the I/R + Ghrelin group was also reversed, and the difference was statistically significant (p < .05). By western blot detection, it was found that after the intervention of GHRP-6 in the rats pretreated with Ghrelin, the expression level of C×43 in the myocardial mitochondria of the rats was significantly decreased. Still, the difference was insignificant compared to that in the I/R + Ghrelin + 5-HD group. Ghrelin protein reduces the mitochondrial ATP value, and reperfusion can maintain the stability of energy metabolism of myocardial cells and protect them. Ghrelin protein protects the myocardium by maintaining the expression of C×43. Ghrelin protein can maintain the expression of C×43 by increasing the activity of the mitochondrial ATP-sensitive potassium channel, thus playing a protective role in cardiomyocytes to a certain extent.

KEYWORDS

• Ischemia/reperfusion
• mitochondrial adenosine triphosphate-sensitive potassium channels
• C×43
• Ghrelin

Showing references and in-text citations exactly as published.

• DOI10.1177/09731296241275304Copy

RELATED ARTICLES

Matched on section and article type within this issue of Pharmacogn. Mag..

• Article · VOLUME 21, ISSUE 2Pinobanksin Attenuates Cerebral Ischemia– Reperfusion Injury in Rats through Mitigating the Inflammatory ResponsesTianmin Bie, Feng Jia, Yongmei Wang, Zhuoyan Pan · pp. 413–422Original Research ArticleSame type: Article
• Article · VOLUME 21, ISSUE 2Extraction and in vitro and in vivo Antioxidant Activity Evaluation of Polyphenols from Lychee PericarpYing Wang, Hong Deng, Chuqin Yu, Junfeng Ban, Shu Zhang · pp. 423–432Original Research ArticleSame type: Article
• Article · VOLUME 21, ISSUE 2Sanggenol L Reduces LPS-induced Myocardial Injury and Inflammation by Activating PI3K/ AKT/mTOR and Inhibiting NF-κB in RatsHaojun Wang, Tao Jin, Yuehan Mao, Yi Wei · pp. 443–453Original Research ArticleSame type: Article
• Article · VOLUME 21, ISSUE 2Identification of Novel Candidate Targets for Fascaplysin through in silico and in vivo Analyses of Shared Targets among Structurally Similar CompoundsKi-Hoon Park, Junyang Jung, Na Young Jeong · pp. 454–466Original Research ArticleSame type: Article